Tumor Organoids hold promise for personalizing cancer therapy

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

As researchers improve ways to quickly and cheaply sequence DNA, the concept of precision medicine is gaining a foothold in the medical community.

When it comes to cancer, a disease that leaves its mark in a patient’s genome, sequencing tumor DNA to tailor treatment plans to individuals seems an obvious application of the technology. “The idea of precision medicine as in individualized treatment, I think that makes so much sense,” says Alice Soragni, a cancer biologist at the University of California, Los Angeles (UCLA) David Geffen School of Medicine. “When you work with a few of these tumors, each and every one is a bit different.”

 

To read the full article, published by Jef Akst on "TheScientist"  - Click HERE